Finding combinations of treatments to protect against Alzheimer's disease

A systems approach for identifying geroprotector synergy in Alzheimer’s disease

NIH-funded research Albert Einstein College of Medicine · NIH-10830378

This study is looking at how different treatments can work together to help protect older adults from Alzheimer's disease, using animal models to find the best combinations that might also help people like you.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine NIH-funded
Lab location1 site (Bronx, United States)
Project IDNIH-10830378 on NIH RePORTER

What this research studies

This research investigates how different treatments can work together to protect against Alzheimer's disease, particularly in older adults. It uses a systems approach to analyze various biological pathways and identify the most effective combinations of interventions. By studying these combinations in animal models, the research aims to predict which treatments could be most beneficial for humans suffering from Alzheimer's. The goal is to develop strategies that can improve health and longevity in patients at risk for this condition.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults who are at risk for or have been diagnosed with Alzheimer's disease.

Not a fit: Patients with early-stage Alzheimer's or those without any cognitive impairment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatment options for Alzheimer's disease, potentially improving quality of life for patients.

How similar studies have performed: Previous research has shown promise in using combinatorial strategies to target aging-related diseases, suggesting that this approach could yield significant results.

Where this research is happening

Bronx, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Diseaseamyloid disease
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.